Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RLM - Realm Therapeutics PLC Sponsored ADR

Previous close
2.55
2.550   100.000%

Share volume: 0
Last Updated: Tue 30 Jul 2019 10:00:01 PM CEST
Medical Specialties: 0%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
52%
Profitability 60%
Dept financing 0%
Liquidity 0%
Performance 70%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$2.55
P/E Ratio 
N/A
DAY RANGE
$2.55 - $2.55
EPS 
$0.00
52 WEEK RANGE
$1.35 - $13.00
52 WEEK CHANGE
-$62.91
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$29,190
AVERAGE 30 VOLUME 
$22,867
Company detail
CEO:
Region: US
Website: http://realmtx.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA.

Recent news